Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.
about
Mechanisms of drug resistance: daptomycin resistancePotential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusA mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.Penetration of daptomycin into bone and synovial fluid in joint replacement.Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary taleEvaluation of two sources of calcium sulfate for a local drug delivery system: a pilot studyColonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.Nitric oxide release: part II. Therapeutic applications.Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerDaptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?Impact of reduced vancomycin MIC on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia.Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis.The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy.Tedizolid (TR-701): a new oxazolidinone with enhanced potency.Current use of daptomycin in cardiac surgery and postoperative intensive care.The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infectionsAntibacterial resistance: an emerging 'zoonosis'?Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia.Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections.Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.Indications for daptomycin use in endocarditis and pacemaker lead infection and outcomes in Leeds, UK.Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multidrug Resistant, Opportunistic Pathogen.Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin.Study on daptomycin use and implementation of an antimicrobial stewardship program.In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?Solid-phase synthesis of fusaricidin/LI-F class of cyclic lipopeptides: Guanidinylation of resin-bound peptidyl amines.Acute focal bacterial nephritis due to methicillin-resistant Staphylococcus aureus in an immunocompetent adult.Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy.Does a learned journal require regular re-vamping?Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.Daptomycin.
P2860
Q26779944-EAF14CD9-8C4A-474F-B916-5AAE106DF140Q27027412-5D04ECA8-9F33-43B3-A9E3-A99E570B4A5BQ30455758-A2901EA1-3B31-4BA3-AD69-FA42389BE738Q33798246-4C1D64C5-3902-492F-9545-FC38D65B25A0Q35090826-046E9F22-16CD-473A-A839-4B44D918B778Q35242592-57CB6A76-558F-4A7B-B49D-0D114406AEC6Q35736907-25FBB243-48A2-4699-A9EB-FAE99A9E4540Q35752011-B893C04C-DDD2-4764-AF79-8A92D94EE0B1Q35926097-FEC0F81B-7FEB-4CC1-A644-B538DC58C6FAQ35926840-46FD7829-D966-489C-A6EE-A54677415B9AQ36093730-117114AE-263A-4B59-A951-6C0255AF8B84Q36200010-04E258DB-8B6F-4216-BB3A-685BD040F64EQ36856946-75004641-3F2B-4A1E-A2C8-A41526E57554Q37263399-06B56231-71DD-4649-A143-A7A215F11C7BQ37676668-C39AA8A7-AE9B-440E-B803-7718968CF092Q37981103-925760B5-05AF-4E5F-870A-52A6F2E2076AQ37982066-9F56C225-5030-446E-8DAC-E75BD8C2DEF4Q37983130-D430AFDF-8993-4010-B39D-20AC9A9C7772Q38086339-DA8ED59D-B08C-4C13-B770-25C7477084D8Q38178280-A2BC05E9-8C3E-4AFC-8ADE-C365C8DEE688Q38263035-0E977F3E-7CFE-48A0-8B00-FB452D273260Q38312543-FFF8A858-EC41-4826-81B8-4DB32EAD1BE3Q38428770-DAD845D3-304A-491D-BBA8-BAF61A1C5345Q38627239-6F716FB4-4EF0-476F-B57C-5160D9EEFFDAQ38845084-7A1E8328-88D5-43E3-8F11-EDF56AFBC0E3Q39016281-3664AB40-3ACE-4800-A7FC-974F5900CF7BQ39573063-8C62D562-A3D8-45FC-91E9-4FD98D6DD899Q40003834-F120D0B5-3009-4D57-8E7B-2E0790F45E20Q40067405-2F8C4B27-6C22-45BB-8126-7411AE017509Q40167823-A5E02344-D314-48ED-ADF6-9B6DE56228D4Q40764649-A4A8C8E6-68F7-40D8-80BA-92808140F4EEQ41862843-9476A5FD-8EB7-47F3-B5AB-2E50D5371C89Q41893358-4F578134-4952-4FB1-85BD-8051B432EB96Q42239433-D5EF6778-5B9E-4272-AE14-D493C89324ABQ43423980-5CEAE32A-7EB4-4DC4-9D6C-58A399330906Q45828036-F8807DFB-A574-476E-9861-8D3AAFD0F4F4Q47116570-E96705AC-8AA0-46C1-9A19-03E2505A8A7DQ47616115-52005F98-2231-46DD-A71F-2B68464A4529
P2860
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emergence of daptomycin resist ...... t--a review of the literature.
@en
Emergence of daptomycin resist ...... t--a review of the literature.
@nl
type
label
Emergence of daptomycin resist ...... t--a review of the literature.
@en
Emergence of daptomycin resist ...... t--a review of the literature.
@nl
prefLabel
Emergence of daptomycin resist ...... t--a review of the literature.
@en
Emergence of daptomycin resist ...... t--a review of the literature.
@nl
P1476
Emergence of daptomycin resist ...... t--a review of the literature.
@en
P2093
D L Paterson
S J van Hal
P2888
P304
P356
10.1007/S10096-010-1128-3
P50
P577
2010-12-30T00:00:00Z